​

Funding Round

Series A - Flindr Therapeutics

Series A - Flindr Therapeutics

Investment Firm

Overview

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

Announced Date

Apr 24, 2024

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

V-Bio Ventures

V-Bio Ventures

V-Bio Ventures is a early_stage_venture firm.

Participant Investors

5

Investor Name
Participant InvestorSwanbridge Capital
Participant InvestorQbic Fund
Participant InvestorBOM
Participant InvestorV-Bio Ventures
Participant InvestorCurie Capital

Round Details and Background

Flindr Therapeutics raised $21400056 on 2024-04-24 in Series A

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 29, 2021
Convertible Note - Flindr Therapeutics
1-undefined
Apr 24, 2024
Series A - Flindr Therapeutics
8-21.4M

Recent Activity

There is no recent news or activity for this profile.